Table 3.
Tumor response and adverse events and initial treatment response.
| PET tumor characteristics 3 mo post-PRRT of patients who tolerated 4 cycles (N = 23), n (%) | |
| Partial response | 5 (21.7) |
| Stable disease | 10 (43.5) |
| Progression | 3 (13.0) |
| Unknown | 5 (21.7) |
| Adverse events (N = 13), n (%) | |
| Grade 1 | 5 (38.5) |
| Grade 2 | 1 (7.7) |
| Grade 3 | 5 (38.5) |
| Grade 4 | 0 (0.0) |
| Grade 5 | 2 (15.4) |
PET = positron emission tomograph, PRRT = peptide receptor radionuclide therapy.